Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joan Hardt

General Practice Oklahoma City, OK Medical Doctor

NPI 1134342892 CMS profile 277955

6424 N Western Ave, Oklahoma City, OK 73116

Open in the dashboard

General payments

$4,002

120 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joan Hardt of Oklahoma City, OK is reported in the CMS Open Payments database as having received $4,002 across 120 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $551 15
2024 General $1,110 20
2023 General $892 16
2022 General $575 22
2021 General $309 12
2020 General $218 13
2019 General $348 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joan Hardt
  • General Practice median
  • Middle half of General Practice
  • National median

In program year 2025, general payments to Joan Hardt were reported at $551. Among 4,774 General Practice profiles paid that year, the median was $106 and the middle half received between $35 and $292.

Show as a table
Year Joan Hardt General Practice median Middle half National median
2019 $348 $107 $37–$285 $163
2020 $218 $75 $25–$213 $114
2021 $309 $93 $30–$272 $132
2022 $575 $103 $36–$279 $149
2023 $892 $106 $34–$276 $160
2024 $1,110 $114 $39–$290 $164
2025 $551 $106 $35–$292 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $2,271 38 payments
  2. Allergan Inc. $1,378 66 payments
  3. Solta Medical, a division of Bausch Health US, LLC $281 13 payments
  4. Aclaris Therapeutics, Inc. $45 2 payments
  5. Apyx Medical Corporation $26 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,592 118 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $409 2 payments
Products named General payments · program years 2019–2025
  1. BOTOX $2,092 51 payments
  2. BOTOX COSMETIC $281 20 payments
  3. ESKATA $45 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

120 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record